FDA Approves Eli Lilly's GLP-1 Pill
IT
•
April 1, 2026
•
0 Views
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Source: https://www.wired.com/feed/rss - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
